CivaTech Oncology, Inc. Announces SS&D Registry Approved For CivaSheet™

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--CivaTech Oncology, a medical device company dedicated to developing innovations in radiation therapy, announced today it has received a Registry Number as a “Sealed Source and Device” for its CivaSheet™ low dose rate (LDR) Palladium 103 source. The FDA cleared CivaSheet™ registration was issued by the State of N.C. Division of Health Service Regulation (DHSR), Radiation Protection Sections (RPS) which is now maintained by the U.S. Nuclear Regulatory Commission (NRC) in the National Sealed Source and Device Registry (NSSDR).

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC